周子娇, 王瑞刚, 张岩, 董飞飞, 伍华, 刘化峰. 桑夏苓术汤治疗脑卒中相关性肺炎的效果[J]. 实用临床医药杂志, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001
引用本文: 周子娇, 王瑞刚, 张岩, 董飞飞, 伍华, 刘化峰. 桑夏苓术汤治疗脑卒中相关性肺炎的效果[J]. 实用临床医药杂志, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001
ZHOU Zijiao, WANG Ruigang, ZHANG Yan, DONG Feifei, WU Hua, LIU Huafeng. Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001
Citation: ZHOU Zijiao, WANG Ruigang, ZHANG Yan, DONG Feifei, WU Hua, LIU Huafeng. Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 62-65. DOI: 10.7619/jcmp.20202001

桑夏苓术汤治疗脑卒中相关性肺炎的效果

Effect of Sangxia Lingzhu Decoction in treating patients with stroke associated pneumonia

  • 摘要:
      目的  探讨桑夏苓术汤对脑卒中相关性肺炎(SAP)患者血清炎症因子和外周血淋巴细胞亚群的影响。
      方法  将110例SAP患者根据随机数字表法分为2组,对照组55例实施常规治疗,观察组55例在对照组基础上服用桑夏苓术汤。治疗前后检测血清炎症因子、外周血淋巴细胞亚群水平,比较2组疾病改善情况及临床疗效。
      结果  2组治疗后C反应蛋白(CRP)、白细胞介素(IL)-1β、IL-4、IL-6、肿瘤坏死因子-α(TNF-α)水平均低于治疗前, T淋巴细胞CD3+、CD4+、CD8+、CD4+/CD8+均高于治疗前,差异均有统计学意义(P < 0.05)。观察组治疗后CRP、IL-1β、IL-4、IL-6、TNF-α水平低于对照组, CD3+、CD4+、CD8+、CD4+/CD8+高于对照组,咳嗽、发热、肺湿啰音及憋喘消失时间短于对照组,差异均有统计学意义(P < 0.05)。观察组总有效率高于对照组,差异均有统计学意义(P < 0.05)。
      结论  桑夏苓术汤可减轻SAP患者体内炎症反应,调节外周血淋巴细胞亚群水平,缩短疾病改善时间,提高疗效。

     

    Abstract:
      Objective  To investigate effect of Sangxia Lingzhu Decoction on serum inflammatory factors and peripheral blood lymphocyte subsets in patients with stroke associated pneumonia (SAP).
      Methods  A total of 110 patients with SAP were selected, and were divided into two groups by random number table method. A total of 55 patients receiving routine treatment were selected as control group, and the rest of 55 patients given Sangxia Lingzhu Decoction based on the control group were selected as observation group. Levels of serum inflammatory factors and peripheral blood lymphocyte subsets were detected before and after treatment. Disease improvement conditions and clinical effects of two groups were compared between two groups.
      Results  The levels of C-reactive protein, interleukin (IL)-1β, IL-4, IL-6 and TNF-α in the two groups after treatment were significantly lower than those before treatment, and the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in two groups after treatment were significantly higher than those before treatment(P < 0.05). After treatment, the levels of C-reactive protein, IL-1β, IL-4, IL-6 and TNF-α in the observation group were significantly lower, the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in the observation group were significantly higher, and disappearance time of cough, fever, lung dampness rale as well as suffocation in the observation group was significantly shorter than that in the control group (P < 0.05). Total effective rate in observation group was significantly higher than that in the control group (P < 0.05).
      Conclusion  Sangxia Lingzhu Decoction can relieve inflammatory reactions in patients with stroke associated pneumonia, regulate the levels of peripheral blood lymphocyte subsets, shorten disease improvement time and improve clinical effect.

     

/

返回文章
返回